MPEP § 2401 — Introduction
Ninth Edition, Revision 01.2024 · last revised R-01.2024
This chapter provides guidance on the practices and procedures pertaining to the rules for deposits of biological materials for patent purposes (37 CFR 1.801 - 1.809) and the rules for the requirements for patent applications containing nucleotide sequence and/or amino acid sequence disclosures under World Intellectual Property Organization (WIPO) Standard ST.25 (37 CFR 1.821 - 1.825) and WIPO Standard ST.26 (37 CFR 1.831 - 1.835).
Cited authority
- 37 CFR 1.801 Biological material
- 37 CFR 1.809 Examination procedures
- 37 CFR 1.821 Nucleotide and/or amino acid sequence disclosures in patent applications
- 37 CFR 1.825 Amendments to add or replace a “Sequence Listing” and CRF copy thereof
- 37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures
- 37 CFR 1.835 Amendment to add or replace a “Sequence Listing XML” in patent applications filed on or after July 1, 2022